Delivery Order SPE2DB24D2205-SPE2DB24FDXVU
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,645.16, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed-price contract with a period of performance through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4563752529 IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also been awarded an indefinite delivery contract (IDC) by DLA with a potential...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, and has a firm fixed price ceiling value of $6,584.22. The contract is not set-aside and has a performance period extending through June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The $1,796.20 contract has an ultimate completion date of August 23, 2022. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
The U.S. Department of Defense awarded a $59,335.20 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a completion date of October 2, 2023, is for the delivery of 4562356439 IPOL VIAL 5ML medical supplies. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,180.20, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price and is scheduled for completion by May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70 and a completion date of September 16, 2024. The contract is a Firm Fixed Price delivery order, which is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of January 30, 2024. This delivery order is part of a larger, single-award indefinite delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, which has a potential value of $2,134.70, is for the delivery of IPOL VIAL 5ML pharmaceutical products to support military treatment programs and facilities. The contract does not have a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566174748 IPOL VIAL 5ML, a pharmaceutical product, with a total ceiling value of $21,347.00. The contract is a firm fixed-price, indefinite delivery contract with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...